Diabetes management

About: Diabetes management is a research topic. Over the lifetime, 6060 publications have been published within this topic receiving 164670 citations.

Quality of life and technology: impact on children and families with diabetes.

Abstract: Ensuring quality of life (QOL) while maintaining glycemic control within targets is an important challenge in type 1 and type 2 diabetes treatment. For children with diabetes, QOL includes enjoying meals, feeling safe in school, and perceiving positive, supportive relationships with parents, siblings, and friends. Yet many treatment-related and psychosocial barriers can interfere with a child’s QOL and their ability to manage diabetes effectively. Diabetes management also imposes considerable lifestyle demands that are difficult and often frustrating for children to negotiate at a young age. Recent advances in diabetes medications and technologies have improved glycemic control in children with diabetes. Two widely used technologies are the insulin pump and continuous glucose monitoring (CGM) system. These technologies provide patients with more flexibility in their daily life and information about glucose fluctuations. Several studies report improvements in glycemic control in children with type 1 diabetes using the insulin pump or sensor-augmented pump therapy. Importantly, these technologies may impact QOL for children and families with diabetes, although they are rarely used or studied in the treatment of children with type 2 diabetes. Further, emerging closed loop and web- and phone-based technologies have great potential for supporting diabetes self-management and perhaps QOL. A deeper understanding and appreciation of the impact of diabetes technology on children’s and parents’ QOL is critical for both the medical and psychological care of diabetes. Thus, the purpose of this review is to discuss the impact of new diabetes technologies on QOL in children, adolescents and families with type 1 diabetes.

Developing and Implementing a Pharmaceutical Care Model in an Ambulatory Care Setting for Patients With Diabetes

Abstract: This study evaluated pharmaceutical care as an adjunct to an existing, coordinated-care program at a Regional Diabetes Center. The progress of a control group receiving the standard pharmacist instruction was compared with two treatment groups receiving additional small group or individual supplementary education for a 2-month period. Outcome evaluation included assessment of individual diabetes management through blood glucose monitoring and responses on a pretest and posttest questionnaire. Patients in the treatment groups demonstrated significantly lower average weekly blood glucose levels and a decreased incidence of hyperglycemic episodes compared with the control group. Questionnaire data for both treatment groups demonstrated a significant increase in patient understanding of diabetes medications and medications for associated illnesses, an increase in knowledge about blood glucose monitoring, and a positive difference in perceptions/attitudes toward diabetes and communication with the pharmacist. ...

Comparison of diabetes management in five countries for general and indigenous populations: an internet-based review

Abstract: The diabetes epidemic is associated with huge human and economic costs, with some groups, such as indigenous populations in industrialised countries, being at especially high risk. Monitoring and improving diabetes care at a population level are important to reduce diabetes-related morbidity and mortality. A set of diabetes indicators has been developed collaboratively among the Organisation for Economic Co-operation and Development (OECD) countries to monitor performance of diabetes care. The aim of this review was to provide an overview of diabetes management in five selected OECD countries (Australia, Canada, New Zealand, the US and the UK), based on data available for general and indigenous populations where appropriate. We searched websites of health departments and leading national organisations related to diabetes care in each of the five countries to identify publicly released reports relevant to diabetes care. We collected data relevant to 6 OECD diabetes indicators on processes of diabetes care (annual HbA1c testing, lipid testing, renal function screening and eye examination) and proximal outcomes (HbA1c and lipid control). Data were drawn from 29 websites, with 14 reports and 13 associated data sources included in this review. Australia, New Zealand, the US and the UK had national data available to construct most of the 6 OECD diabetes indicators, but Canadian data were limited to two indicators. New Zealand and the US had national level diabetes care data for indigenous populations, showing relatively poorer care among these groups when compared with general populations. The US and UK performed well across the four process indicators when compared with Australia and New Zealand. For example, annual HbA1c testing and lipid testing were delivered to 70-80% of patients in the US and UK; the corresponding figures for Australia and New Zealand were 50-60%. Regarding proximal outcomes, HbA1c control for patients in Australia and New Zealand tended to be relatively better than patients in the US and UK. Substantial efforts have been made in the five countries to develop routine data collection systems to monitor performance of diabetes management. Available performance data identify considerable gaps in clinical care of diabetes across countries. Policy makers and health service providers across countries can learn from each other to improve data collection and delivery of diabetes care at the population level.

Antioxidants in Diabetes Management

Abstract: The best ebooks about Antioxidants In Diabetes Management that you can get for free here by download this Antioxidants In Diabetes Management and save to your desktop. This ebooks is under topic such as antioxidants in diabetes management pwcgba antioxidants in diabetes management shahz antioxidants in diabetes management sgscc delivery aspects of antioxidants in diabetes management antioxidants in diabetes management oxidative stress and antioxidants in diabetes management kemara antioxidants in diabetes management oxidative stress and antioxidants in diabetes management adduha antioxidants in diabetes management voojoo antioxidants in diabetes management oxidative stress and antioxidants in diabetes management oxidative stress and antioxidants in diabetes management oxidative stress and antioxidants in diabetes management msrint antioxidants in diabetes management daizer antioxidants in diabetes management oxidative stress and antioxidants in diabetes management oxidative stress and antioxidants in diabetes management oxidative stress and phytochemicals for diabetes management bentham open antioxidants in diabetes management oxidative stress and antioxidants in diabetes management oxidative stress and antioxidants in diabetes management bagabl antioxidants in diabetes management oxidative stress and antioxidants in diabetes management saitrh antioxidants in diabetes management oxidative stress and antioxidants in the prevention and treatment of diabetic the role for vitamin and mineral supplements in diabetes oxidative stress in diabetes mellitus oatext how effective are antioxidant supplements in obesity and antioxidants in diabetes management oxidative stress and antioxidants in diabetes management ccsplc 106 2011 106-125 antioxidants in the treatment of diabetes